-Ars Technica
BioVie Presents Data Highlighting Role Of Insulin Resistance And Neuroinflammation In The Development Of Mild To Moderate In Alzheimer’s Disease
BioVie Inc., (NASDAQ:BIVI) ("BioVie" or the "Company") a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced